Structures by: Essaghouani A.
Total: 9
1-Benzyl-4-phenyl-1<i>H</i>-1,5-benzodiazepin-2(3<i>H</i>)-one
C22H18N2O
IUCrData (2016) 1, 12 x161988
a=14.6973(7)Å b=5.9179(3)Å c=19.8537(9)Å
α=90° β=93.4610(10)° γ=90°
3-Chloro-6-nitro-1-[(1-octyl-1<i>H</i>-1,2,3-triazol-4-yl)methyl]-1<i>H</i>-indazole
C18H23ClN6O2
IUCrData (2017) 2, 2 x170146
a=25.3512(9)Å b=14.9091(5)Å c=10.7525(3)Å
α=90° β=101.725(2)° γ=90°
1-Ethyl-4-phenyl-1<i>H</i>-1,5-benzodiazepin-2(3<i>H</i>)-one
C17H16N2O
IUCrData (2016) 1, 4 x160661
a=16.5042(4)Å b=9.6896(3)Å c=18.1221(5)Å
α=90° β=90° γ=90°
3-Phenylisoxazolin-5-one
C9H7NO2
IUCrData (2017) 2, 1 x170032
a=9.9869(6)Å b=5.3008(3)Å c=13.9874(9)Å
α=90° β=93.106(2)° γ=90°
1-(5-Nitro-1<i>H</i>-indazol-1-yl)ethanone
C9H7N3O3
IUCrData (2016) 1, 6 x160939
a=7.6004(3)Å b=7.9200(3)Å c=9.3621(3)Å
α=113.0200(10)° β=91.404(2)° γ=118.350(2)°
(3<i>S</i>)-3,8-Dibromo-4-phenyl-2,3-dihydro-1<i>H</i>-1,5-benzodiazapin-2-one
C15H10Br2N2O
IUCrData (2017) 2, 3 x170389
a=7.8931(8)Å b=9.9295(10)Å c=10.2411(11)Å
α=101.7510(10)° β=105.968(2)° γ=109.4820(10)°
5-Nitro-1-(prop-2-en-1-yl)-1<i>H</i>-indazole
C10H9N3O2
IUCrData (2017) 2, 7 x171091
a=6.9549(5)Å b=11.6778(9)Å c=12.2165(9)Å
α=90° β=90° γ=90°
2-(2-Oxo-4-phenyl-2,3-dihydro-1<i>H</i>-1,5-benzodiazepin-1-yl)acetic acid
C17H14N2O3
IUCrData (2017) 2, 1 x170120
a=17.9752(8)Å b=17.4403(8)Å c=9.2472(4)Å
α=90° β=102.8920(10)° γ=90°
(<i>Z</i>)-7,8-Dichloro-4-(2-oxopropylidene)-4,5-dihydro-1<i>H</i>-1,5-benzodiazepin-2(3<i>H</i>)-one
C12H10Cl2N2O2
Acta Crystallographica Section E (2015) 71, 12 o1059-o1060
a=7.6789(4)Å b=13.2199(6)Å c=12.4129(7)Å
α=90° β=102.561(3)° γ=90°